Search Our Scientific Publications & Authors

Publications
find publications by category +
Translate page:

Implementation and Outcomes of a Comprehensive Tobacco Free Workplace Program in Opioid Treatment Centers.

Authors:
Matthew Taing Vijay Nitturi Tzuan A Chen Bryce Kyburz Isabel Martinez Leal Virmarie Correa-Fernández Ezemenari M Obasi Teresa Williams Kathleen Casey Daniel P O'Connor Litty Koshy Maggie Britton Kelli Drenner Lorraine R Reitzel

Int J Environ Res Public Health 2021 12 26;19(1). Epub 2021 Dec 26.

Department of Psychological, Health & Learning Sciences, The University of Houston, 3657 Cullen Blvd Stephen Power Farish Hall, Houston, TX 77204, USA.

Tobacco use is exceedingly high among individuals receiving care for opioid addiction, but not commonly addressed by clinicians in treatment settings. Taking Texas Tobacco Free (TTTF) is a comprehensive tobacco-free workplace (TFW) program that builds treatment centers' capacity to address tobacco use with evidence-based tobacco cessation policies and practices. Here, we examine the process and outcomes of TTTF's implementation within 7 opioid addiction centers. Program goals were structured according to the RE-AIM framework. Pre- and post-implementation data were collected from client facing and non-client facing employees to assess changes in education, training receipt, knowledge, and intervention behaviors, relative to program goals. Centers reported tobacco screenings conducted and nicotine replacement therapy (NRT) delivered through 6 months post-implementation. Overall, 64.56% of employees participated in TTTF-delivered tobacco education, with a 54.9% gain in tobacco control and treatment knowledge ( < 0.0001), and significant increases in exposure to education about tobacco use and harms among individuals with opioid use disorder ( = 0.0401). There were significant gains in clinicians' receipt of training in 9/9 tobacco education areas ( ≤ 0.0118). From pre- to post-implementation, there were mean increases in the use of the 5A's (ask, advise, assess, assist, and arrange) and other evidence-based interventions for tobacco cessation, with statistically significant gains seen in NRT provision/referral ( < 0.0001). Several program goals were achieved or exceeded; however, 100% center participation in specialized clinical trainings was among notable exceptions. One program withdrew due to competing pandemic concerns; all others implemented comprehensive TFW policies. Overall, TTTF may have improved participating opioid treatment centers' capacity to address tobacco use, although study limitations, including lower post-implementation evaluation response rates, suggest that results require replication in other opioid addiction treatment settings.

Download full-text PDF

 Source
http://dx.doi.org/10.3390/ijerph19010239DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8744608PMC
December 2021

Publication Analysis

Top Keywords

opioid addiction
12
tobacco
12
program goals
12
opioid treatment
8
centers' capacity
8
tobacco cessation
8
treatment settings
8
address tobacco
8
tobacco education
8
pre- post-implementation
8
treatment centers'
8
capacity address
8
tobacco free
8
opioid
6
treatment
6
program
6
disorder 00401
4
00001 increases
4
increases exposure
4
exposure education
4

Keyword Occurance

Similar Publications

Bridge clinic implementation of "72-hour rule" methadone for opioid withdrawal management: Impact on opioid treatment program linkage and retention in care.

Authors:
Jessica L Taylor Jordana Laks Paul J Christine Jessica Kehoe James Evans Theresa W Kim Natalija M Farrell Cedric S White Zoe M Weinstein Alexander Y Walley

Drug Alcohol Depend 2022 May 14;236:109497. Epub 2022 May 14.

Grayken Center for Addiction, Boston Medical Center, Boston, MA, USA; Clinical Addiction Research and Education (CARE) Unit, Section of General Internal Medicine, Department of Medicine, Boston University School of Medicine and Boston Medical Center, Boston, MA, USA.

Background: Methadone for opioid use disorder (OUD) treatment is restricted to licensed opioid treatment programs (OTPs) with substantial barriers to entry. Underutilized regulations allow non-OTP providers to administer methadone for opioid withdrawal for up to 72 h while arranging ongoing care. Our low-barrier bridge clinic implemented a new pathway to treat opioid withdrawal and facilitate OTP linkage utilizing the "72-hour rule. Read More

View Article and Full-Text PDF
May 2022
Similar Publications

How access to addictive drugs affects the supply of substance abuse treatment: Evidence from Medicare Part D.

Authors:
Matthew T Knowles

Health Econ 2022 May 23. Epub 2022 May 23.

Department of Economics, Vanderbilt University, Nashville, Tennessee, USA.

This paper documents how substance abuse treatment (SAT) providers and services respond to increases in population-level opioid addiction. I do this by exploiting the implementation of Medicare Part D as an exogenous increase in the availability of prescription opioids. Starting in 2006, states with higher shares of the population eligible for Medicare Part D experienced increases in residential and hospital inpatient SAT facilities, beds dedicated to SAT, and SAT facilities offering medication-assisted treatment, relative to states with lower shares. Read More

View Article and Full-Text PDF
May 2022
Similar Publications

Treatment outcomes associated with medications for opioid use disorder (MOUD) among criminal justice-referred admissions to residential treatment in the U.S., 2015-2018.

Authors:
Gerald J Stahler Jeremy Mennis L A R Stein Steven Belenko Damaris J Rohsenow Heidi E Grunwald Lauren Brinkley-Rubinstein Rosemarie A Martin

Drug Alcohol Depend 2022 May 14;236:109498. Epub 2022 May 14.

Center for Alcohol & Addiction Studies, Brown University School of Public Health, United States.

Aims: To examine the use and association of medications for opioid use disorder (MOUD) with treatment completion and retention for criminal justice referred (CJR) admissions to residential treatment.

Methods: A retrospective analysis of the Treatment Episode Dataset-Discharge (TEDS-D; 2015-2018) for adults (N = 205,348) admitted to short-term (ST) (< 30 days) or long-term (LT) (>30 days) residential treatment for OUD. Outcomes were MOUD in treatment plans, and treatment completion and retention (ST >10 days; LT > 90 days). Read More

View Article and Full-Text PDF
May 2022
Similar Publications

The Impact of the Covid-19 Pandemic on Smoking Among Vulnerable Populations.

Authors:
Rhiannon C Wiley Anthony C Oliver Miranda B Snow Janice Y Bunn Anthony J Barrows Jennifer W Tidey Dustin C Lee Stacey C Sigmon Diann E Gaalema Sarah H Heil Catherine Markesich Andrea C Villanti Stephen T Higgins

Nicotine Tob Res 2022 May 23. Epub 2022 May 23.

Vermont Center on Behavior and Health, Larner College of Medicine, University of Vermont, Burlington, VT.

Aim: While accumulating evidence suggests that people modified their smoking during the ongoing COVID-19 pandemic, it remains unclear whether those most at risk for tobacco-related health disparities did so. The current study examined changes in smoking among several vulnerable smoker populations during the COVID-19 pandemic.

Methods: A web-based survey was distributed in 2020 to 709 adults with socioeconomic disadvantage, affective disorders, or opioid use disorder who participated in a previous study investigating the effects of very low nicotine content (VLNC) cigarettes on smoking. Read More

View Article and Full-Text PDF
May 2022
Similar Publications
}